315 related articles for article (PubMed ID: 30699122)
1. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo.
de Freitas CS; Higa LM; Sacramento CQ; Ferreira AC; Reis PA; Delvecchio R; Monteiro FL; Barbosa-Lima G; James Westgarth H; Vieira YR; Mattos M; Rocha N; Hoelz LVB; Leme RPP; Bastos MM; Rodrigues GOL; Lopes CEM; Queiroz-Junior CM; Lima CX; Costa VV; Teixeira MM; Bozza FA; Bozza PT; Boechat N; Tanuri A; Souza TML
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007072. PubMed ID: 30699122
[TBL] [Abstract][Full Text] [Related]
2. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure.
Mendes ÉA; Pilger DRB; Santos Nastri ACS; Malta FM; Pascoalino BDS; Carneiro D'Albuquerque LA; Balan A; Freitas LHG; Durigon EL; Carrilho FJ; Rebello Pinho JR
Ann Hepatol; 2019; 18(6):816-824. PubMed ID: 31594756
[TBL] [Abstract][Full Text] [Related]
3. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus.
Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J
Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus.
Zandi K; Amblard F; Amichai S; Bassit L; Tao S; Jiang Y; Zhou L; Ollinger Russell O; Mengshetti S; Schinazi RF
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262759
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX.
Assunção-Miranda I; Cruz-Oliveira C; Neris RL; Figueiredo CM; Pereira LP; Rodrigues D; Araujo DF; Da Poian AT; Bozza MT
J Appl Microbiol; 2016 Mar; 120(3):790-804. PubMed ID: 26759117
[TBL] [Abstract][Full Text] [Related]
6. Yellow fever vaccine protects mice against Zika virus infection.
Vicente Santos AC; Guedes-da-Silva FH; Dumard CH; Ferreira VNS; da Costa IPS; Machado RA; Barros-Aragão FGQ; Neris RLS; Dos-Santos JS; Assunção-Miranda I; Figueiredo CP; Dias AA; Gomes AMO; de Matos Guedes HL; Oliveira AC; Silva JL
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009907. PubMed ID: 34735450
[TBL] [Abstract][Full Text] [Related]
7. RNA interference inhibits yellow fever virus replication in vitro and in vivo.
Pacca CC; Severino AA; Mondini A; Rahal P; D'avila SG; Cordeiro JA; Nogueira MC; Bronzoni RV; Nogueira ML
Virus Genes; 2009 Apr; 38(2):224-31. PubMed ID: 19169857
[TBL] [Abstract][Full Text] [Related]
8. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
[TBL] [Abstract][Full Text] [Related]
9. Activity of T-1106 in a hamster model of yellow Fever virus infection.
Julander JG; Furuta Y; Shafer K; Sidwell RW
Antimicrob Agents Chemother; 2007 Jun; 51(6):1962-6. PubMed ID: 17420215
[TBL] [Abstract][Full Text] [Related]
10. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
Kum DB; Boudewijns R; Ma J; Mishra N; Schols D; Neyts J; Dallmeier K
Emerg Microbes Infect; 2020; 9(1):520-533. PubMed ID: 32116148
[TBL] [Abstract][Full Text] [Related]
11. The Role of NS5 Protein in Determination of Host Cell Range for Yellow Fever Virus.
Laurent-Rolle M; Morrison J
DNA Cell Biol; 2019 Dec; 38(12):1414-1417. PubMed ID: 31633391
[TBL] [Abstract][Full Text] [Related]
12. Structure of the yellow fever NS5 protein reveals conserved drug targets shared among flaviviruses.
Dubankova A; Boura E
Antiviral Res; 2019 Sep; 169():104536. PubMed ID: 31202975
[TBL] [Abstract][Full Text] [Related]
13. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM
Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746
[TBL] [Abstract][Full Text] [Related]
14. MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target.
Albarnaz JD; De Oliveira LC; Torres AA; Palhares RM; Casteluber MC; Rodrigues CM; Cardozo PL; De Souza AM; Pacca CC; Ferreira PC; Kroon EG; Nogueira ML; Bonjardim CA
Antiviral Res; 2014 Nov; 111():82-92. PubMed ID: 25241249
[TBL] [Abstract][Full Text] [Related]
15. Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism.
Miorin L; Laurent-Rolle M; Pisanelli G; Co PH; Albrecht RA; García-Sastre A; Morrison J
J Virol; 2019 Jul; 93(14):. PubMed ID: 31043530
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model.
Julander JG; Jha AK; Choi JA; Jung KH; Smee DF; Morrey JD; Chu CK
Antiviral Res; 2010 Jun; 86(3):261-7. PubMed ID: 20227442
[TBL] [Abstract][Full Text] [Related]
17. A mouse model for studying viscerotropic disease caused by yellow fever virus infection.
Meier KC; Gardner CL; Khoretonenko MV; Klimstra WB; Ryman KD
PLoS Pathog; 2009 Oct; 5(10):e1000614. PubMed ID: 19816561
[TBL] [Abstract][Full Text] [Related]
18. Tiratricol inhibits yellow fever virus replication through targeting viral RNA-dependent RNA polymerase of NS5.
Ren H; Wang J; Tang H; Qian X; Xia B; Luo Z; Xu Z; Qi Z; Zhao P
Antiviral Res; 2023 Nov; 219():105737. PubMed ID: 37879570
[TBL] [Abstract][Full Text] [Related]
19. Persistence of Yellow fever virus outside the Amazon Basin, causing epidemics in Southeast Brazil, from 2016 to 2018.
Rezende IM; Sacchetto L; Munhoz de Mello É; Alves PA; Iani FCM; Adelino TÉR; Duarte MM; Cury ALF; Bernardes AFL; Santos TA; Pereira LS; Dutra MRT; Ramalho DB; de Thoisy B; Kroon EG; Trindade GS; Drumond BP
PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006538. PubMed ID: 29864115
[TBL] [Abstract][Full Text] [Related]
20. Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo.
Qian X; Wu B; Tang H; Luo Z; Xu Z; Ouyang S; Li X; Xie J; Yi Z; Leng Q; Liu Y; Qi Z; Zhao P
Emerg Microbes Infect; 2022 Dec; 11(1):873-884. PubMed ID: 35249454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
